XML 14 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
REVENUES $ 7,526 $ 4,670 $ 16,773 $ 7,118
COST OF REVENUES (6,066) (4,248) (13,677) (6,446)
GROSS PROFIT 1,460 422 3,096 672
RESEARCH AND DEVELOPMENT EXPENSES [1] (7,118) (6,353) (22,389) (23,700)
Less - grants 729 1,297 2,545 4,800
RESEARCH AND DEVELOPMENT EXPENSES, NET (6,389) (5,056) (19,844) (18,900)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [1] (2,836) (2,014) (8,187) (6,215)
OPERATING LOSS (7,765) (6,648) (24,935) (24,443)
FINANCIAL EXPENSES (3,680) (910) (8,809) (2,715)
FINANCIAL INCOME 8 268 1,670 606
LOSS FROM CHANGE IN FAIR VALUE OF CONVERTIBLE NOTES EMBEDDED DERIVATIVE     (38,061) 0
FINANCIAL EXPENSES, NET (3,672) (642) (45,200) (2,109)
LOSS FROM CONTINUING OPERATIONS (11,437) (7,290) (70,135) (26,552)
LOSS FROM DISCONTINUED OPERATIONS 0 0 0 (189)
NET LOSS FOR THE PERIOD $ (11,437) $ (7,290) $ (70,135) $ (26,741)
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED        
Loss from continuing operations $ (0.09) $ (0.07) $ (0.55) $ (0.27)
Loss from discontinued operations       (0.00)
Net loss per share of common stock $ (0.09) $ (0.07) $ (0.55) $ (0.27)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE-BASIC AND DILUTED 132,549,001 99,821,970 128,223,722 99,766,245
[1] Includes share-based compensation